Eposter / Safety Evaluation of Christensenella minuta as a Novel Microbiome-based Biotherapy to Treat Obesity
We are pleased to present our poster highlighting safety and first efficacy results of our Xla1 biotherapy targeting obesity and its associated metabolic disorders.
In the same category
Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease
Apr 11, 2022
more +
Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow...
Feb 16, 2022
more +
Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation...
Sep 1, 2021
more +